Astrazeneca expands cancer treatment stable with purchase of Canada-based Fusion March 19, 2024 The Cambridge-based pharma firm is paying $2bn cash up front as part of the deal
Astrazeneca: Pharma giant snaps up rare disease biotech firm Amoylt March 14, 2024 The acquisition, which is meant to "bolster" Astrazenca's rare disease arm Alexion, brings with it a Phase III investigational therapeutic peptide meant for hypoparathyroidism
Spring Budget 2024: Astrazeneca to invest £650m in Cambridge and Liverpool March 6, 2024 AstraZeneca is to invest £650m in the UK, Chancellor Jeremy Hunt has announced in his Spring Budget.
FTSE 100: London creeps into the green, Currys soars as takeover battle looks likely February 19, 2024 On the FTSE 100, Astrazeneca rose to the top of the index after its Tagrisso drug received positive clinical trial results.